List of Tables
    Table 1. Retinal Disorders Therapy Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Retinal Disorders Therapy Market Trends
    Table 3. Retinal Disorders Therapy Market Drivers
    Table 4. Retinal Disorders Therapy Market Challenges
    Table 5. Retinal Disorders Therapy Market Restraints
    Table 6. Global Retinal Disorders Therapy Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Retinal Disorders Therapy Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Retinal Disorders Therapy Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Retinal Disorders Therapy Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Retinal Disorders Therapy Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Retinal Disorders Therapy Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Retinal Disorders Therapy Revenue Share by Player, 2017-2022
    Table 13. Global Retinal Disorders Therapy Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Retinal Disorders Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retinal Disorders Therapy as of 2021)
    Table 15. Top Players of Retinal Disorders Therapy in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Retinal Disorders Therapy Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Retinal Disorders Therapy Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Retinal Disorders Therapy Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Retinal Disorders Therapy Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Retinal Disorders Therapy Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Retinal Disorders Therapy Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Retinal Disorders Therapy Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Retinal Disorders Therapy Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Retinal Disorders Therapy Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Retinal Disorders Therapy Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Retinal Disorders Therapy Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Retinal Disorders Therapy Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Retinal Disorders Therapy Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. ALLERGAN Company Details
    Table 31. ALLERGAN Business Overview
    Table 32. ALLERGAN Retinal Disorders Therapy Product
    Table 33. ALLERGAN Revenue in Retinal Disorders Therapy Business (2017-2022) & (US$ Million)
    Table 34. ALLERGAN Recent Development
    Table 35. AbbVie Company Details
    Table 36. AbbVie Business Overview
    Table 37. AbbVie Retinal Disorders Therapy Product
    Table 38. AbbVie Revenue in Retinal Disorders Therapy Business (2017-2022) & (US$ Million)
    Table 39. AbbVie Recent Development
    Table 40. Alimera Sciences Company Details
    Table 41. Alimera Sciences Business Overview
    Table 42. Alimera Sciences Retinal Disorders Therapy Product
    Table 43. Alimera Sciences Revenue in Retinal Disorders Therapy Business (2017-2022) & (US$ Million)
    Table 44. Alimera Sciences Recent Development
    Table 45. Janssen Biotech Company Details
    Table 46. Janssen Biotech Business Overview
    Table 47. Janssen Biotech Retinal Disorders Therapy Product
    Table 48. Janssen Biotech Revenue in Retinal Disorders Therapy Business (2017-2022) & (US$ Million)
    Table 49. Janssen Biotech Recent Development
    Table 50. Swedish Orphan Biovitrum Company Details
    Table 51. Swedish Orphan Biovitrum Business Overview
    Table 52. Swedish Orphan Biovitrum Retinal Disorders Therapy Product
    Table 53. Swedish Orphan Biovitrum Revenue in Retinal Disorders Therapy Business (2017-2022) & (US$ Million)
    Table 54. Swedish Orphan Biovitrum Recent Development
    Table 55. Roche Company Details
    Table 56. Roche Business Overview
    Table 57. Roche Retinal Disorders Therapy Product
    Table 58. Roche Revenue in Retinal Disorders Therapy Business (2017-2022) & (US$ Million)
    Table 59. Roche Recent Development
    Table 60. Bristol-Myers Squibb Company Details
    Table 61. Bristol-Myers Squibb Business Overview
    Table 62. Bristol-Myers Squibb Retinal Disorders Therapy Product
    Table 63. Bristol-Myers Squibb Revenue in Retinal Disorders Therapy Business (2017-2022) & (US$ Million)
    Table 64. Bristol-Myers Squibb Recent Development
    Table 65. Genzyme Company Details
    Table 66. Genzyme Business Overview
    Table 67. Genzyme Retinal Disorders Therapy Product
    Table 68. Genzyme Revenue in Retinal Disorders Therapy Business (2017-2022) & (US$ Million)
    Table 69. Genzyme Recent Development
    Table 70. Genentech Company Details
    Table 71. Genentech Business Overview
    Table 72. Genentech Retinal Disorders Therapy Product
    Table 73. Genentech Revenue in Retinal Disorders Therapy Business (2017-2022) & (US$ Million)
    Table 74. Genentech Recent Development
    Table 75. OCULAR THERAPEUTIX Company Details
    Table 76. OCULAR THERAPEUTIX Business Overview
    Table 77. OCULAR THERAPEUTIX Retinal Disorders Therapy Product
    Table 78. OCULAR THERAPEUTIX Revenue in Retinal Disorders Therapy Business (2017-2022) & (US$ Million)
    Table 79. OCULAR THERAPEUTIX Recent Development
    Table 80. Bausch & Lomb Company Details
    Table 81. Bausch & Lomb Business Overview
    Table 82. Bausch & Lomb Retinal Disorders Therapy Product
    Table 83. Bausch & Lomb Revenue in Retinal Disorders Therapy Business (2017-2022) & (US$ Million)
    Table 84. Bausch & Lomb Recent Development
    Table 85. UCBCares Company Details
    Table 86. UCBCares Business Overview
    Table 87. UCBCares Retinal Disorders Therapy Product
    Table 88. UCBCares Revenue in Retinal Disorders Therapy Business (2017-2022) & (US$ Million)
    Table 89. UCBCares Recent Development
    Table 90. Aier Eye Hospital Company Details
    Table 91. Aier Eye Hospital Business Overview
    Table 92. Aier Eye Hospital Retinal Disorders Therapy Product
    Table 93. Aier Eye Hospital Revenue in Retinal Disorders Therapy Business (2017-2022) & (US$ Million)
    Table 94. Aier Eye Hospital Recent Development
    Table 95. Alcon Holdings, Inc. Company Details
    Table 96. Alcon Holdings, Inc. Business Overview
    Table 97. Alcon Holdings, Inc. Retinal Disorders Therapy Product
    Table 98. Alcon Holdings, Inc. Revenue in Retinal Disorders Therapy Business (2017-2022) & (US$ Million)
    Table 99. Alcon Holdings, Inc. Recent Development
    Table 100. Eyebright Medical Company Details
    Table 101. Eyebright Medical Business Overview
    Table 102. Eyebright Medical Retinal Disorders Therapy Product
    Table 103. Eyebright Medical Revenue in Retinal Disorders Therapy Business (2017-2022) & (US$ Million)
    Table 104. Eyebright Medical Recent Development
    Table 105. Kanghong Pharmaceutical Company Details
    Table 106. Kanghong Pharmaceutical Business Overview
    Table 107. Kanghong Pharmaceutical Retinal Disorders Therapy Product
    Table 108. Kanghong Pharmaceutical Revenue in Retinal Disorders Therapy Business (2017-2022) & (US$ Million)
    Table 109. Kanghong Pharmaceutical Recent Development
    Table 110. Huaxia Eye Hospital Company Details
    Table 111. Huaxia Eye Hospital Business Overview
    Table 112. Huaxia Eye Hospital Retinal Disorders Therapy Product
    Table 113. Huaxia Eye Hospital Revenue in Retinal Disorders Therapy Business (2017-2022) & (US$ Million)
    Table 114. Huaxia Eye Hospital Recent Development
    Table 115. Xingqi Pharmaceutical Company Details
    Table 116. Xingqi Pharmaceutical Business Overview
    Table 117. Xingqi Pharmaceutical Retinal Disorders Therapy Product
    Table 118. Xingqi Pharmaceutical Revenue in Retinal Disorders Therapy Business (2017-2022) & (US$ Million)
    Table 119. Xingqi Pharmaceutical Recent Development
    Table 120. Research Programs/Design for This Report
    Table 121. Key Data Information from Secondary Sources
    Table 122. Key Data Information from Primary Sources
List of Figures
    Figure 1. Retinal Disorders Therapy Product Picture
    Figure 2. Global Retinal Disorders Therapy Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Retinal Disorders Therapy Market Size 2017-2028 (US$ Million)
    Figure 4. United States Retinal Disorders Therapy Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Retinal Disorders Therapy Market Size 2017-2028 (US$ Million)
    Figure 6. United States Retinal Disorders Therapy Market Share in Global 2017-2028
    Figure 7. Retinal Disorders Therapy Report Years Considered
    Figure 8. Product Picture of Age Related Macular Degeneration
    Figure 9. Product Picture of Diabetic Retinopathy
    Figure 10. Product Picture of Ocular Inflammatory Disease (Uveitis)
    Figure 11. Product Picture of Macular Hole
    Figure 12. Global Retinal Disorders Therapy Market Share by Type in 2022 & 2028
    Figure 13. Global Retinal Disorders Therapy Market Size by Type (2017-2028) & (US$ Million)
    Figure 14. Global Retinal Disorders Therapy Market Share by Type (2017-2028)
    Figure 15. United States Retinal Disorders Therapy Market Share by Type in 2022 & 2028
    Figure 16. United States Retinal Disorders Therapy Market Size by Type (2017-2028) & (US$ Million)
    Figure 17. United States Retinal Disorders Therapy Market Share by Type (2017-2028)
    Figure 18. Product Picture of Hospitals
    Figure 19. Product Picture of Clinics
    Figure 20. Product Picture of Others
    Figure 21. Global Retinal Disorders Therapy Market Share by Application in 2022 & 2028
    Figure 22. Global Retinal Disorders Therapy Market Size by Application (2017-2028) & (US$ Million)
    Figure 23. Global Retinal Disorders Therapy Market Share by Application (2017-2028)
    Figure 24. United States Retinal Disorders Therapy Market Share by Application in 2022 & 2028
    Figure 25. United States Retinal Disorders Therapy Market Size by Application (2017-2028) & (US$ Million)
    Figure 26. United States Retinal Disorders Therapy Market Share by Application (2017-2028)
    Figure 27. North America Retinal Disorders Therapy Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 28. United States Retinal Disorders Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 29. Canada Retinal Disorders Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. Europe Retinal Disorders Therapy Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 31. Germany Retinal Disorders Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. France Retinal Disorders Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. U.K. Retinal Disorders Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Italy Retinal Disorders Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Russia Retinal Disorders Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Asia-Pacific Retinal Disorders Therapy Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 37. China Retinal Disorders Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Japan Retinal Disorders Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. South Korea Retinal Disorders Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. India Retinal Disorders Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Australia Retinal Disorders Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. China Taiwan Retinal Disorders Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Indonesia Retinal Disorders Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Thailand Retinal Disorders Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Malaysia Retinal Disorders Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Latin America Retinal Disorders Therapy Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 47. Mexico Retinal Disorders Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Brazil Retinal Disorders Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Argentina Retinal Disorders Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Middle East & Africa Retinal Disorders Therapy Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 51. Turkey Retinal Disorders Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia Retinal Disorders Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. UAE Retinal Disorders Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. ALLERGAN Revenue Growth Rate in Retinal Disorders Therapy Business (2017-2022)
    Figure 55. AbbVie Revenue Growth Rate in Retinal Disorders Therapy Business (2017-2022)
    Figure 56. Alimera Sciences Revenue Growth Rate in Retinal Disorders Therapy Business (2017-2022)
    Figure 57. Janssen Biotech Revenue Growth Rate in Retinal Disorders Therapy Business (2017-2022)
    Figure 58. Swedish Orphan Biovitrum Revenue Growth Rate in Retinal Disorders Therapy Business (2017-2022)
    Figure 59. Roche Revenue Growth Rate in Retinal Disorders Therapy Business (2017-2022)
    Figure 60. Bristol-Myers Squibb Revenue Growth Rate in Retinal Disorders Therapy Business (2017-2022)
    Figure 61. Genzyme Revenue Growth Rate in Retinal Disorders Therapy Business (2017-2022)
    Figure 62. Genentech Revenue Growth Rate in Retinal Disorders Therapy Business (2017-2022)
    Figure 63. OCULAR THERAPEUTIX Revenue Growth Rate in Retinal Disorders Therapy Business (2017-2022)
    Figure 64. Bausch & Lomb Revenue Growth Rate in Retinal Disorders Therapy Business (2017-2022)
    Figure 65. UCBCares Revenue Growth Rate in Retinal Disorders Therapy Business (2017-2022)
    Figure 66. Aier Eye Hospital Revenue Growth Rate in Retinal Disorders Therapy Business (2017-2022)
    Figure 67. Alcon Holdings, Inc. Revenue Growth Rate in Retinal Disorders Therapy Business (2017-2022)
    Figure 68. Eyebright Medical Revenue Growth Rate in Retinal Disorders Therapy Business (2017-2022)
    Figure 69. Kanghong Pharmaceutical Revenue Growth Rate in Retinal Disorders Therapy Business (2017-2022)
    Figure 70. Huaxia Eye Hospital Revenue Growth Rate in Retinal Disorders Therapy Business (2017-2022)
    Figure 71. Xingqi Pharmaceutical Revenue Growth Rate in Retinal Disorders Therapy Business (2017-2022)
    Figure 72. Bottom-up and Top-down Approaches for This Report
    Figure 73. Data Triangulation
    Figure 74. Key Executives Interviewed